4 Von Willebrand Disease Clinical Trials in Ann Arbor, MI (2026)

Q: How do I join a clinical trial in Ann Arbor?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you.

Recruiting Von Willebrand Disease Studies in Ann Arbor

NCT06610201Recruiting

A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

The purpose of this screening study is to accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeds in participants with Von Willebrand Disease (V...

Ann Arbor, MI200 participantsHemab ApS

View Study Details

NCT06754852Recruiting

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

This is a first-in-human (FIH), Phase 1/2, 3-part open-label, dose escalation, safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and efficacy study evaluating HMB-002 in participants w...

Ann Arbor, MIPHASE1108 participantsHemab ApS

View Study Details

NCT07115004Recruiting

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)...

Ann Arbor, MIPHASE360 participantsVega Therapeutics, Inc

View Study Details

NCT05500807Recruiting

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder affecting up to 0.1% of the population, is usually characterized by mucocutaneous bleeding, HMB, surgical bleeding or other ...

Ann Arbor, MIPHASE140 participantsBleeding and Clotting Disorders Institute Peoria, Illinois

View Study Details

About Von Willebrand Disease Clinical Trials in Ann Arbor

Von Willebrand disease is the most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, a protein needed for blood clotting. Most cases are mild with excessive bleeding during surgery or dental work. Treatment includes desmopressin and von Willebrand factor concentrates.

There are currently 4 von willebrand disease clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 408 participants. Research is being sponsored by Hemab ApS, Vega Therapeutics, Inc, Bleeding and Clotting Disorders Institute Peoria, Illinois. Clinical trial participation is free and participants receive study-related medical care at no cost.

Von Willebrand Disease Clinical Trials in Ann Arbor — FAQ

Are there von willebrand disease clinical trials in Ann Arbor?

Yes, there are 4 von willebrand disease clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What von willebrand disease treatments are being tested?

The 4 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for von willebrand disease.

Data updated October 15, 2026 from ClinicalTrials.gov